Vittoria Biotherapeutics develops gene-edited cell therapies.  they provide next-generation, paradigm-shifting T-cell therapeutics that address unmet medical needs. Senza5 Technology from viTToria improves the efficacy, safety, and utility of cell-based treatments in preclinical settings.

Biotechnology

Health Data

Test & Measurement

viTToria biotherapeutics

Nicholas Siciliano

Jay Mohr

Keith Westby

Lori Forrest

Steven Yang

Aditya Nimmagadda

Adam Snook

Rosemary Mazanet

The Leadership Team at Vittoria Biotherapeutics drives the strategic vision and operational excellence necessary to develop and deliver groundbreaking gene-edited cell therapies. Comprising experienced founders and executives, this team oversees clinical advancements, regulatory compliance, and partnerships to ensure the successful implementation of Senza5 Technology in addressing unmet medical needs.

Leadership Team

Scientific Advisory Team

Leadership Team

About

Team members

Other teams at viTToria biotherapeutics

Scientific Advisory Team